Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants

被引：4

作者：

Chen, Zhaochun ^{[1
]}

Zhang, Peng ^{[2
]}

Matsuoka, Yumiko ^{[3
]}

Tsybovsky, Yaroslav ^{[4
]}

West, Kamille ^{[5
]}

Santos, Celia ^{[3
]}

Boyd, Lisa F. ^{[6
]}

Nguyen, Hanh ^{[1
]}

Pomerenke, Anna ^{[1
]}

Stephens, Tyler ^{[4
]}

Olia, Adam S. ^{[7
]}

Zhang, Baoshan ^{[7
]}

De Giorgi, Valeria ^{[5
]}

Holbrook, Michael R. ^{[8
]}

Gross, Robin ^{[8
]}

Postnikova, Elena ^{[8
]}

Garza, Nicole L. ^{[9
]}

Johnson, Reed F. ^{[9
]}

Margulies, David H. ^{[6
]}

Kwong, Peter D. ^{[7
]}

Alter, Harvey J. ^{[5
]}

Buchholz, Ursula J. ^{[3
]}

Lusso, Paolo ^{[2
]}

Farci, Patrizia ^{[1
]}

机构：

[1] NIAID, Hepat Pathogenesis Sect, Lab Infect Dis, NIH, Bethesda, MD 20892 USA

[2] NIAID, Lab Immunoregulat, NIH, Bethesda, MD USA

[3] NIAID, RNA Viruses Sect, Lab Infect Dis, NIH, Bethesda, MD USA

[4] Leidos Biomed Res Inc, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD USA

[5] NIH, Dept Transfus Med, Clin Ctr, Bethesda, MD USA

[6] NIAID, Mol Biol Sect, Lab Immune Syst Biol, NIH, Bethesda, MD USA

[7] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD USA

[8] NIAID, Integrated Res Facil, NIH, Frederick, MD USA

[9] NIAID, SARS CoV 2 Virol Core, Lab Viral Dis, NIH, Bethesda, MD USA

来源：

CELL REPORTS | 2022年 / 41卷 / 05期

基金：

美国国家卫生研究院;

关键词：

RECEPTOR-BINDING DOMAIN; CRYO-EM STRUCTURE; VALIDATION; SPIKE; REPLICATION; INFECTION; LIBRARIES; TOOLS; MODEL;

D O I：

10.1016/j.celrep.2022.111528

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The emergence and global spread of the SARS-CoV-2 Omicron variants, which carry an unprecedented num-ber of mutations, raise serious concerns due to the reduced efficacy of current vaccines and resistance to therapeutic antibodies. Here, we report the generation and characterization of two potent human monoclonal antibodies, NA8 and NE12, against the receptor-binding domain of the SARS-CoV-2 spike protein. NA8 inter-acts with a highly conserved region and has a breadth of neutralization with picomolar potency against the Beta variant and the Omicron BA.1 and BA.2 sublineages and nanomolar potency against BA.2.12.1 and BA.4. Combination of NA8 and NE12 retains potent neutralizing activity against the major SARS-CoV-2 var-iants of concern. Cryo-EM analysis provides the structural basis for the broad and complementary neutral-izing activity of these two antibodies. We confirm the in vivo protective and therapeutic efficacies of NA8 and NE12 in the hamster model. These results show that broad and potent human antibodies can overcome the continuous immune escape of evolving SARS-CoV-2 variants.

引用

页数：25

共 50 条

[31] A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
Wang, Pengfei
Casner, Ryan G.
Nair, Manoj S.
Yu, Jian
Guo, Yicheng
Wang, Maple
Chan, Jasper F-W
Cerutti, Gabriele
Iketani, Sho
Liu, Lihong
Sheng, Zizhang
Chen, Zhiwei
Yuen, Kwok-Yung
Kwong, Peter D.
Huang, Yaoxing
Shapiro, Lawrence
Ho, David D.
EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 147 - 157
[32] Reinfection by SARS-CoV-2 by divergent Omicron sublineages, 16 days apart
Viviane Girardi
Juliana Schons Gularte
Meriane Demoliner
Mariana Soares da Silva
Micheli Filippi
Vyctoria Malayhka de Abreu Góes Pereira
Alana Witt Hansen
Raquel Borba Rosa
Juliane Deise Fleck
Fernando Rosado Spilki
Brazilian Journal of Microbiology, 2023, 54 : 1847 - 1851
[33] Monoclonal antibodies neutralizing circulating SARS-CoV-2 variants of concern
Kovacech, Branislav
Fialova, Lubica
Filipcik, Peter
Skrabana, Rostislav
Zilkova, Monika
Kovac, Andrej
Rolkova, Gabriela Paulikova
Tomkova, Katarina
Csokova, Natalia Turic
Markova, Karina
Skrabanova, Michaela
Majerova, Petra
Hanes, Jozef
Cehlar, Ondrej
Cente, Martin
Piestansky, Juraj
Slavikova, Monika
Borsova, Kristina
Cabanova, Viktoria
Brejova, Bronislava
Vinar, Tomas
Nosek, Jozef
Klempa, Boris
Eyer, Ludek
Honig, Vaclav
Palus, Martin
Ruzek, Daniel
Vyhlidalova, Tereza
Strakova, Petra
Mrazkova, Blanka
Zudova, Dagmar
Koubkova, Gizela
Novosadova, Vendula
Prochazka, Jan
Sedlacek, Radislav
Zilka, Norbert
Kontsekova, Eva
EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 53 - 54
[34] Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
Xia, Hongjie
Yeung, Jason
Kalveram, Birte
Bills, Cody J.
Chen, John Yun-Chung
Kurhade, Chaitanya
Zou, Jing
Widen, Steven G.
Mann, Brian R.
Kondor, Rebecca
Davis, C. Todd
Zhou, Bin
Wentworth, David E.
Xie, Xuping
Shi, Pei-Yong
EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
[35] Reinfection by SARS-CoV-2 by divergent Omicron sublineages, 16 days apart
Girardi, Viviane
Gularte, Juliana Schons
Demoliner, Meriane
da Silva, Mariana Soares
Filippi, Micheli
Pereira, Vyctoria Malayhka de Abreu Goes
Hansen, Alana Witt
Rosa, Raquel Borba
Fleck, Juliane Deise
Spilki, Fernando Rosado
BRAZILIAN JOURNAL OF MICROBIOLOGY, 2023, 54 (03) : 1847 - 1851
[36] SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
Gruell, Henning
Vanshylla, Kanika
Korenkov, Michael
Tober-Lau, Pinkus
Zehner, Matthias
Munn, Friederike
Janicki, Hanna
Augustin, Max
Schommers, Philipp
Sander, Leif Erik
Kurth, Florian
Kreer, Christoph
Klein, Florian
CELL HOST & MICROBE, 2022, 30 (09) : 1231 - +
[37] Antibodies induced by an ancestral SARS-CoV-2 strain that cross-neutralize variants from Alpha to Omicron BA.1
Windsor, Ian W.
Tong, Pei
Lavidor, Olivia
Moghaddam, Ali Sanjari
McKay, Lindsay G. A.
Gautam, Avneesh
Chen, Yuezhou
MacDonald, Elizabeth A.
Yoo, Duck Kyun
Griffths, Anthony
Wesemann, Duane R.
Harrison, Stephen C.
SCIENCE IMMUNOLOGY, 2022, 8 (90)
[38] Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants
Zheng, Qianqian
Duan, Liangwei
Jiang, Zhihua
Gu, Tingxuan
Zhang, Bojie
Li, Jiaoyang
Zhang, Yang
Zhang, Shiyu
Liang, Yinming
Wang, Hui
GENES & DISEASES, 2023, 10 (03) : 664 - 667
[39] Omicron variants of SARS-CoV-2 and long COVID
Yang, Chengliang
Zhao, Hedi
Shannon, Casey P.
Tebbutt, Scott J.
FRONTIERS IN IMMUNOLOGY, 2022, 13
[40] Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants
Ueno, Mikako
Iwata-Yoshikawa, Naoko
Matsunaga, Akihiro
Okamura, Tadashi
Saito, Sho
Ashida, Shinobu
Yoshida, Isao
Nagashima, Mami
Asakura, Hiroyuki
Yaoita, Yuu
Suzuki, Jun
Sadamasu, Kenji
Yoshimura, Kazuhisa
Kutsuna, Satoshi
Shiwa-Sudo, Nozomi
Nagata, Noriyo
Suzuki, Tadaki
Suzuki, Akinori
Okamoto, Miwa
Kimura, Moto
Ohmagari, Norio
Miura, Ryu
Ishizaka, Yukihito
ANTIVIRAL RESEARCH, 2022, 201

← 1 2 3 4 5 →